Abridged presentation of the MCV 5-dose opportunity for organizational stakeholders. Linksbridge/Sassenach (2022)
Sassenach
29th June 2022
549
Zero Dose Community of Practice MCV 5-dose presentation. Linksbridge/Sassenach, 2022
Sassenach
6th June 2022
715
MR 5-dose Total Systems Effectiveness Analysis (TSE). Linksbridge/Sassenach (2021).
Sassenach
6th June 2022
543
Report of the Regional Immunization Technical Advisory Group meeting. WHO AFRO, 2019.
Sassenach
6th June 2022
696
The value of tailoring vial sizes to populations and locations. Wedlock et al. (2018)
Sassenach
6th June 2022
561
Coverage, Cost, and Safety Impacts of Primary Container Choice. IVAC/Johns Hopkins (2013)
Sassenach
6th June 2022
484